Showing results (1-10 of 256) with videos related to
Sort By:
Pageof 26
Health Economics|June 16, 2001
Cost prediction models for the comparison of two groupsA R Willan, B J O'BrienHealth Economics|May 29, 1999
Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials dataA R Willan, B J O'BrienHealth Economics|July 1, 1996
Confidence intervals for cost-effectiveness ratios: an application of Fieller's theoremA R Willan, B J O'BrienStatistics in Medicine|December 18, 2001
Cost-effectiveness analysis when the WTA is greater than the WTPA R Willan, B J O'Brien, R A LeyvaControlled Clinical Trials|April 1, 1997
Benefit-risk ratios in the assessment of the clinical evidence of a new therapyA R Willan, B J O'Brien, D J CookControlled Clinical Trials|June 1, 2001
Analysis, sample size, and power for estimating incremental net health benefit from clinical trial dataA R WillanControlled Clinical Trials|June 1, 1994
Power function arguments in support of an alternative approach for analyzing management trialsA R WillanBiometrics|March 1, 1988
Using the maximum test statistic in the two-period crossover clinical trialA R WillanPharmacoeconomics|October 13, 2001
Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradicationK Agro, G Blackhouse, R Goeree, et al.Pageof 26